Data gathered: July 12
AI Stock Analysis - Amedisys (AMED)
Analysis generated September 26, 2024. Powered by Chat GPT.
Amedisys, Inc. is a home health care company based in Baton Rouge, Louisiana. The firm primarily operates in three segments: Home Health Care, Hospice Care, and Personal Care. Amedisys delivers a broad range of health care services to enable its patients to recover comfortably at home, thus reducing hospital readmission rates and lowering overall costs. With a robust network of compassionate healthcare professionals, Amedisys has established itself as a pivotal player in the home health care industry, committed to improving the quality of life for its patients.
Stock Alerts - Amedisys (AMED)
 |
Amedisys | July 10 Web Traffic is down by 48.6% over the last month. |
|
Amedisys | July 2 Job postings are up by 24.3% in the last couple of days. |
|
Amedisys | June 4 Job postings are down by 16.6% in the last couple of days. |
|
Amedisys | June 1 Job postings are down by 29.8% in the last couple of days. |
Download our app to get future alerts delivered in real-time.
Alternative Data for Amedisys
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 1,803 | Sign up | Sign up | Sign up |
| Sentiment | N/A | Sign up | Sign up | Sign up |
| Webpage traffic | 90,000 | Sign up | Sign up | Sign up |
| Employee Rating | 66 | Sign up | Sign up | Sign up |
| Google Trends | 36 | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 86 | Sign up | Sign up | Sign up |
| Facebook Followers | 17,948 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 810 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,225 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| Youtube Subscribers | 275 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 50 | Sign up | Sign up | Sign up |
| Linkedin Employees | 9,167 | Sign up | Sign up | Sign up |
About Amedisys
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care.
| Price | $97.18 |
| Target Price | Sign up |
| Volume | 217,450 |
| Market Cap | $3.21B |
| Year Range | $83.78 - $98.39 |
| Dividend Yield | 0% |
| PE Ratio | 35.86 |
| Analyst Rating | 17% buy |
| Industry | Medical Care Facilities |
In the news
 |
Amedisys (AMED) and The Competition Critical AnalysisJuly 8 - ETF Daily News |
|
Contrasting Amedisys (AMED) & Its RivalsJuly 5 - ETF Daily News |
 |
How DexCom, Insulet, and Amedisys Might Be Affected by Medicare CutsJuly 1 - Biztoc.com |
 |
Can Amedisys, Inc. (NASDAQ:AMED) Performance Keep Up Given Its Mixed Bag Of Fundamentals?June 25 - Yahoo |
|
GAMMA Investing LLC Purchases 3,332 Shares of Amedisys, Inc. (NASDAQ:AMED)June 21 - ETF Daily News |
|
Yousif Capital Management LLC Sells 284 Shares of Amedisys, Inc. (NASDAQ:AMED)June 19 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 595M | 334M | 261M | 61M | 89M | 1.250 |
| Q4 '24 | 598M | 345M | 253M | -20M | 3.2M | 0.960 |
| Q3 '24 | 588M | 338M | 250M | 41M | 26M | 1.000 |
| Q2 '24 | 591M | 461M | 131M | 32M | 70M | 1.320 |
| Q1 '24 | 571M | 454M | 118M | 14M | 58M | 1.030 |
Insider Transactions View All
| Guidroz Allyson filed to sell 8,114 shares at $96. May 9 '25 |
| Guidroz Allyson filed to sell 8,761 shares at $92. March 6 '25 |
| North Michael Paul filed to sell 4,164 shares at $86.4. March 8 '23 |
| Bohnert Denise M. filed to sell 11,850 shares at $115. June 27 '22 |
| Kemmerly David L filed to sell 18,816 shares at $175.2. April 4 '22 |
Similar companies
Read more about Amedisys (AMED) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Amedisys?
The Market Cap of Amedisys is $3.21B.
What is Amedisys' PE Ratio?
As of today, Amedisys' PE (Price to Earnings) ratio is 35.86.
What is the current stock price of Amedisys?
Currently, the price of one share of Amedisys stock is $97.18.
How can I analyze the AMED stock price chart for investment decisions?
The AMED stock price chart above provides a comprehensive visual representation of Amedisys' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Amedisys shares. Our platform offers an up-to-date AMED stock price chart, along with technical data analysis and alternative data insights.
Does AMED offer dividends to its shareholders?
As of our latest update, Amedisys (AMED) does not offer dividends to its shareholders. Investors interested in Amedisys should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Amedisys?
Some of the similar stocks of Amedisys are Encompass Health, Brookdale Senior Living, DaVita, Tenet Healthcare, and Encompass Health.
.